Liftstream is an executive search recruitment company in the life sciences sector
David Motts’ NEA weighs in on rare diseases
Authored by Karl Simpson
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases
Tagged AstraZeneca, Cambridge MA, Clarus Ventures, Cydan, David Mott, DMD, Dr. Cristina Csimma, Duchenne Muscular Dystrophy, GSK, International Rare Diseases Research Consortium, James McArthur, MedImmune, NEA, Orphan Drug, orphan drug accelerator, Prosensa, Rare Disease, Treat-NMD, Virdante Pharmaceuticals, Wyeth
Leave a comment